Cargando…

A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease

Abnormal motor behaviors in Parkinson’s disease (PD) result from striatal dysfunction due to an imbalance between dopamine and glutamate transmissions that are integrated by dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32). c-Abelson tyrosine kinase (c-Abl) phosphorylates cyclin-depe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanabe, Akie, Yamamura, Yukio, Kasahara, Jiro, Morigaki, Ryoma, Kaji, Ryuji, Goto, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929858/ https://www.ncbi.nlm.nih.gov/pubmed/24600352 http://dx.doi.org/10.3389/fncel.2014.00050

Ejemplares similares

Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice
por: Yamamura, Yukio, et al.
Publicado: (2013)

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL
por: Weisberg, E, et al.
Publicado: (2006)

Correction: AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL
por: Weisberg, E, et al.
Publicado: (2019)

Clinicopathological Phenotype and Genetics of X-Linked Dystonia–Parkinsonism (XDP; DYT3; Lubag)
por: Kawarai, Toshitaka, et al.
Publicado: (2017)

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017)

Putaminal Mosaic Visualized by Tyrosine Hydroxylase Immunohistochemistry in the Human Neostriatum
por: Morigaki, Ryoma, et al.
Publicado: (2016)

Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role
por: Koizumi, Hidetaka, et al.
Publicado: (2013)

Turning on the Left Side Electrode Changed Depressive State to Manic State in a Parkinson’s Disease Patient Who Received Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Case Report
por: Kinoshita, Makoto, et al.
Publicado: (2018)

Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson’s disease
por: Kadoguchi, Naoto, et al.
Publicado: (2014)

Development of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin-fixed and paraffin-embedded tissues from autopsied human brains
por: Goto, Satoshi, et al.
Publicado: (2015)

Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation
por: Morigaki, Ryoma, et al.
Publicado: (2016)

c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism
por: Zhou, Yu, et al.
Publicado: (2018)

The 2022 AMN Virtual Congress – Day 2
por: Dobran, Stefana-Andrada, et al.
Publicado: (2022)

Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2
por: Koizumi, Hidetaka, et al.
Publicado: (2014)

Postsynaptic Density Protein 95 in the Striosome and Matrix Compartments of the Human Neostriatum
por: Morigaki, Ryoma, et al.
Publicado: (2015)

Therapeutic Devices for Motor Symptoms in Parkinson’s Disease: Current Progress and a Systematic Review of Recent Randomized Controlled Trials
por: Fujikawa, Joji, et al.
Publicado: (2022)

Dopamine-Induced Changes in Gα(olf) Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of l-DOPA-Induced Dyskinesia in Parkinsonian Mice
por: Morigaki, Ryoma, et al.
Publicado: (2017)

Nerve ultrasound characterizes AMN polyneuropathy as inhomogeneous and focal hypertrophic
por: Rattay, Tim W., et al.
Publicado: (2018)

Acute macular neuroretinopathy (AMN) following COVID-19 vaccination
por: Drüke, Daniela, et al.
Publicado: (2021)

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
por: Paramarta, Jacqueline E., et al.
Publicado: (2016)

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
por: Carracedo, Miguel, et al.
Publicado: (2020)

Long-Term Follow-Up of 12 Patients Treated with Bilateral Pallidal Stimulation for Tardive Dystonia
por: Koyama, Hiroshi, et al.
Publicado: (2021)

Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
por: Pagan, Fernando, et al.
Publicado: (2016)

Amn1 governs post-mitotic cell separation in Saccharomyces cerevisiae
por: Fang, Ou, et al.
Publicado: (2018)

The 2022 Academy for Multidisciplinary Neurotraumatology (AMN) Virtual Congress – Day 1
por: Dobran, Stefana-Andrada, et al.
Publicado: (2022)

Extensive intracranial arterial stenoses in conjunction with the use of tyrosine kinase inhibitor Nilotinib
por: Alshiekh‐Nasany, Ruham, et al.
Publicado: (2016)

Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib
por: Leitão, Juliana Ribeiro, et al.
Publicado: (2016)

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
por: Pagan, Fernando L., et al.
Publicado: (2020)

Nilotinib in Parkinson's disease: A systematic review and meta-analysis
por: Xie, Xiaolu, et al.
Publicado: (2022)

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease
por: Jeong, Seong Ho, et al.
Publicado: (2022)

Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease
por: Trinh, Ilene, et al.
Publicado: (2023)

Cranial geometry in patients with dystonia and Parkinson’s disease
por: Fujikawa, Joji, et al.
Publicado: (2023)

The birth of neurotrauma: a historical perspective from the Academy of Multidisciplinary Neurotraumatology (AMN)
por: Muresanu, Dafin, et al.
Publicado: (2021)

AMN Congress 2022 – Report of the panel on minimizing the risks of failure in TBI research
por: Gherman, Alexandra-Mihaela, et al.
Publicado: (2022)

AMN Congress 2022 – Report of the panel on the future focus of the Academy for Multidisciplinary Neurotraumatology
por: Gherman, Alexandra-Mihaela, et al.
Publicado: (2022)

The Academy for Multidisciplinary Neurotraumatology (AMN) Congress 2023: 20 Years of Excellence in Neurotraumatology
por: Dobran, Stefana-Andrada, et al.
Publicado: (2023)

COVID-19 Related Acute Macular Neuroretinopathy (AMN): A Case Series
por: Vu, Truong Andy, et al.
Publicado: (2023)

Associations of striatal dopamine transporter binding with motor and non‐motor symptoms in early Parkinson's disease
por: Yang, Zhengjie, et al.
Publicado: (2023)

Quantitative activation-induced manganese-enhanced MRI reveals severity of Parkinson’s disease in mice
por: Kikuta, Satomi, et al.
Publicado: (2015)

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease
por: Pagan, Fernando L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vnr6o50mlhkv7rjhgb4kdja1c8